Adverse events, contraindications, interactions and high-risk flags — per peptide.
Safety & Side Effects is the site's ethical core. It consolidates the documented adverse events, contraindicated populations, drug interactions and high-risk flags for every peptide, anchored by the master benefits-vs-side-effects comparison table. Where a peptide carries a serious or under-appreciated risk — tumor-angiogenesis theory, product-purity hazards, melanoma surveillance — this is where we say so without hedging.
The anchor safety guide to the peptide class — separating what the molecule does from what is actually in the vial, with the load-bearing contraindications, interactions, injection risks, and the shifting 2026 FDA/WADA landscape.
A single, evidence-graded map of what the published literature actually shows for the peptide field — separating the handful of Grade-A, FDA-approved peptides from the much larger group whose claims rest on animal data, mechanism, or marketing alone.
The risks fall into a few groups. First, product-quality hazards: most non-approved peptides come from unregulated "research chemical" vendors, and independent testing has found endotoxins, heavy metals and inaccurate dosing in such vials — often the largest practical risk. Second, compound-specific dangers: melanotan II (priapism, melanoma signals), IGF-1 analogs and insulin (severe hypoglycemia), and the theoretical tumor-angiogenesis concern with pro-angiogenic peptides. Third, the simple fact that most peptides have minimal long-term human safety data.
Certain populations carry clear precautionary contraindications: anyone with active or prior malignancy (because several peptides are pro-angiogenic and could theoretically promote tumor growth), pregnant or breastfeeding individuals (no human safety data for most peptides), and children (no data). WADA-tested athletes face a different kind of prohibition — many peptides are banned in sport at all times. Because no clinical population has established eligibility for most of these compounds, any use should be discussed with a licensed clinician first.
Every page carries a prominent medical disclaimer, and high-risk peptides carry additional, unambiguous warnings. We grade efficacy claims conservatively and never let a strong benefit claim overshadow a serious risk. Regulatory and anti-doping statements are date-stamped and sourced to FDA, WADA and DEA primary materials. The site is informational and editorial — it is explicitly not medical advice, not a buying guide, and not a channel for sourcing unapproved peptides.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.
